The Bio Bridge Initiative
What is the Bio-Bridge Initiative?
The Bio-Bridge Initiative is a partnership between Australia and the Texas
Medical Centre (TMC) in Houston, USA.
The aim is to create a two way flow of capital and resources, through
collaborations in research, clinical trials and commercialisation.
The partnership links Australian firms and ingenuity to TMC - the largest
medical centre within the largest health market in the world – to develop a
sustainable growth platform for Australian innovation in medical devices,
diagnostics and digital health.
What is the Texas Medical Center (TMC)
The Texas Medical Center (TMC) in Houston, USA, is the largest medical
centre in the world and largest employer in Houston, with an extensive
campus of 21 hospitals, 50 non-profit organisations and eight academic and
research institutions. TMC concentrates its operations and research on
genomics, regenerative medicine, innovation, clinical trials and health
The Texas Medical Center Accelerator program (TMCx)
The Bio-Bridge Initiative provides Australian medical technology firms a
place in the four month Texas Medical Center (TMC) Accelerator Program
This allows startups a workspace within the world's largest medical center,
access to a network of over 120 expert advisers from the 21 Texas Medical
Center hospitals and a tailored curriculum, to clinically validate products
and establish US market fit for their solutions.
Participants benefit by attending a variety of workshops and hands-on
events to gain insights from experts in every facet of running a
health-related business in the US, including: clinical trials, FDA
regulations, HIPAA/HITECH compliance, hospital procurement, commercial
pilots, intellectual property, licensing, fundraising, marketing and other
In addition, participants work with the TMCx team to refine strategies and
build relationships across the Texas Medical Center. Companies have the
opportunity to network with key thought leaders and mentors during the
Advisor Pitch Event, the TMC Expert Forum and other scheduled sessions.
The four-month program culminates with TMCx Demo Day, an exclusive
presentation to hundreds of investors, corporate partners, hospital
stakeholders, media and other guests.
As part of the short term objective of the Bio-Bridge initiative, TMC
invites 4-6 Australian innovative SMEs into the TMC Accelerator program
(TMCx). This is a competitive process, however Australian companies are
invited through a separate process where you will compete and be assessed
against other Australian firms only.
This program is offered at NO participation cost to successful
companies and TMC does not retain equity.
Hear from previous participants
Stuart Ward, CEO of Ward MM and Ken Saman, CEO of Personify Care share insights from their recent participation in TMCx.
For enquiries and more information contact us